Astrid Kramer

4PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

Haoyue Wang, Astrid Kramer, Marjolein J E Greuter

|Feb 07, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.

Astrid Kramer, Lucas F van Schaik, Daan van den Broek

|Aug 23, 2024
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.

Astrid Kramer, Marjolein J E Greuter, Suzanna J Schraa

|Dec 07, 2023
A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Astrid Kramer, Carmen Rubio-Alarcón, Daan van den Broek

Pageof 1